Aktuellt
SENASTE
The Q1 results showed sales and earnings broadly in-line with our expectations (no consensus). Growth (+17% y/y) primarily driven by a continued strong trend for SyMRI with additional support from GE and the new agreement with UI. With the Q1 numbers being pretty much in-line with our estimates, we see limited estimate revisions post the Q1 numbers. Neutral share price reaction warranted.
LÄS MER
